newsfilter
← Latest News
ACCESS Newswire·

Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government

TORONTO, ON / ACCESSWIRE / October 12, 2023 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, has secured a commitment of up to C$23